CIK: 1604646 - Address: C/O Astria Therapeutics, Inc., 22 Boston Wharf Road, 10Th Floor, Boston, MA 02110
8 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg
S%ret111-1-1289173038
S%wins10010000040

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
1/11/23 20:29
1/9/23
JNCEJounce Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagCole Hugh MMAOCOOS.m-181.110-17-13110D
1/11/22 20:55
1/7/22
JNCEJounce Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagCole Hugh MMAOChief BuS.m-676.880-10-1364D
1/25/21 17:36
1/22/21
JNCEJounce Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagCole Hugh MMAOChief BuS.d-21511.950-18-2847D
1/11/21 06:19
1/7/21
JNCEJounce Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagCole Hugh MMAOChief BuS.m-436.890-6-1055D
8/18/20 20:29
8/14/20
JNCEJounce Therapeutics, Inc.HealthBioPrdBiological Products, (No DiagCole Hugh MMAOChief BuS.m-104.710-2-361D
1/10/20 08:53
1/7/20
JNCEJounce Therapeutics, Inc.HealthBioPrdBiological Products, (No DiagCole Hugh MMAOChief BuS-207.780-3-734D
8/16/19 21:00
8/14/19
JNCEJounce Therapeutics, Inc.HealthBioPrdBiological Products, (No DiagCole Hugh MMAOChief BuS.m-93.990-2-636D
6/29/16 16:25
6/28/16
ARIAAriad Pharmaceuticals IncDEHealthBioPrdBiological Products, (No DiagCole Hugh MMAOSVP,ChieS.d-427.0533-6-1730D12-101315-8-19-5-6-1-1289173

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact